SCHEMBL6551807

SCHEMBL6551807

c1ccc(-c2c3ccccc3cc3ccccc23)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.54
LMNA P02545 4/20 0.54
CCR1 P32246 3/20 0.54
CCR5 P51681 3/20 0.54
CCR8 P51685 3/20 0.54
METAP1 P53582 2/20 0.54
CYP1A2 P05177 2/20 0.54
POLB P06746 1/20 0.54
BLM P54132 1/20 0.54
HIF1A Q16665 1/20 0.54
DOHH Q9BU89 1/20 0.54
P4HTM Q9NXG6 1/20 0.54
NPC1 O15118 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
RAB9A P51151 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
TP53 P04637 4/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15835177 0.87 DHODH (0.50) KDM4ELMNACCR1CCR5CCR8
SCHEMBL19497664 0.85 KDM4E (0.52) KDM4ELMNACCR1CCR5CCR8
SCHEMBL31147813 0.84 CCR1 (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL17008146 0.84 KDM4E (0.68) KDM4ELMNACCR1CCR5CCR8
SCHEMBL29769628 0.84 KDM4E (0.68) KDM4ELMNACCR1CCR5CCR8
SCHEMBL973168 0.83 ADORA3 (0.49) KDM4ELMNACCR1CCR5CCR8
SCHEMBL12579263 0.83 DHODH (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL18904437 0.83 KDM4E (0.46) KDM4ELMNACCR1CCR5CCR8
SCHEMBL2550644 0.82 KDM4E (0.48) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30500150 0.82 CCR1 (0.46) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118745147-A Cobalt-catalyzed method for preparing isonicotinic acid compound by taking carbon dioxide as carboxyl source 南开大学 2024-10-08 CN disclosed
CN-117430549-A Method for preparing isonicotinic acid compound by taking carbon dioxide as carboxyl source 南开大学 2024-01-23 CN disclosed
CN-110023305-B Organic light-emitting compound and organic electroluminescent element using same 索路思高新材料有限公司 2022-08-09 CN disclosed
US-20200392259-A1 ORTHOMETALLATED CATALYST COMPONENTS FOR OLEFIN POLYMERIZATION AND COPOLYMERIZATION ARZOUMANIDIS GREGORY G (US) 2020-12-17 US disclosed
EP-1484380-A1 POLYMERIC PHOSPHORS, PROCESS FOR PRODUCTION THEREOF, PHOSPHORESCENT COMPOSITIONS AND ARTICLES MADE BY USING THE SAME JSR Corporation (JP) 2004-12-08 EP disclosed
EP-1484381-A1 PHOSPHORS, PROCESS FOR PRODUCTION THEREOF, PHOSPHORESCENT COMPOSITIONS AND ARTICLES MADE BY USING THE SAME JSR Corporation (JP) 2004-12-08 EP disclosed
US-20040106006-A1 Phosphors, process for production thereof, phosphorescent compositions and articles made by using the same JSR CORPORATION (JP) 2004-06-03 US disclosed
US-20040091739-A1 Polymeric phosphorescent agent and production process thereof, and luminescent composition and applied products thereof JSR CORPORATION (JP) 2004-05-13 US disclosed
US-5631264-A NEUROLOGICAL DISORDERS SANOFI WINTHROP, INC. (US) 1997-05-20 US disclosed
US-5554620-A Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof STERLING WINTHROP INC. (US) 1996-09-10 US disclosed
US-5455248-A Treatment or prevention of neurodegenerative disorders or neurotoxic injuries; binding to PCP receptors STERLING WINTHROP INC. (US) 1995-10-03 US disclosed
US-5434159-A Neurodegenerative disorders STERLING WINTHROP INC. (US) 1995-07-18 US disclosed
US-5430036-A Neurodegenerative disorders, neurotoxic injuries STERLING WINTHROP INC. (US) 1995-07-04 US disclosed
EP-0656359-A1 Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof STERLING WINTHROP INC. (US) 1995-06-07 EP disclosed
EP-0648769-A1 12-Hetero-substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizium salts and compositions and method of use thereof STERLING WINTHROP INC. (US) 1995-04-19 EP disclosed
US-5380729-A Treatment or prevention of neurodegenerative disorders or neurotoxic injuries STERLING WINTHROP INC. (US) 1995-01-10 US disclosed